Brief: Control Bionics Says HY Revenues From Ordinary Activities Up 23% To A$2.9 Million
23/02/2023 06:47
Feb 23 (Reuters) - Control Bionics Ltd CBL.AX :
* HY REVENUES FROM ORDINARY ACTIVITIES UP 23% TO A$2.9
MILLION
* FULL YEAR FORECASTS REMAIN UNCHANGED
* CONTINUES TO REVIEW ITS CASH POSITION AND OPTIONS FOR
RAISING
NEW CAPITAL
* TOTAL COMPREHENSIVE LOSS FOR HY ATTRIBUTABLE A$3 MILLION
VERSUS
LOSS A$3.1 MILLION
Source text for Eikon: ID:nASX1wv3Vn
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device